Sensyne Health's CEO (LON:SENS) Lord Paul Drayson talks to Proactive London about their first digital health product in the U.S that can remotely monitor for diabetes in pregnancy.
The group's partner Cognizant will oversee the roll-out of GDm-Health across the Atlantic.
Drayson talks through the advantages for the patient, doctor and the hospital. And during the coronavirus pandemic this product means less women are needed to visit hospitals during their pregnancy and get the piece of mind from home.
Over 20% of pregnancies in the States are affected by diabetes every year.